Renal allograft survival can be predicted by histomorphometric assessment of extracellular matrix in 6-month protocol biopsies.
Nicholson
M L
ML
University Department of Surgery, Leicester General Hospital, UK.
Bailey
E
E
Williams
S
S
Harris
K P
KP
Furness
P N
PN
D001707:Biopsy, Needle; D003094:Collagen / Q000032:analysis; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006801:Humans; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D007962:Leukocytes / Q000473:pathology; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D019063:Tenascin / Q000032:analysis; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D019063:Tenascin; D003094:Collagen